Safety and immunogenicity of tetanus-diphtheria-acellular pertussis vaccine administered to children 10 or 11 years of age
GS Marshall, V Pool, DP Greenberg… - Clinical and Vaccine …, 2014 - Am Soc Microbiol
Boosting immunity to tetanus, diphtheria, and pertussis through the use of Tdap vaccines is
routinely recommended at 11 to 12 years of age; some states, however, require Tdap for …
routinely recommended at 11 to 12 years of age; some states, however, require Tdap for …
Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults
ME Pichichero, MB Rennels, KM Edwards, MM Blatter… - Jama, 2005 - jamanetwork.com
ContextIncreasing reports of pertussis among US adolescents, adults, and their infant
contacts have stimulated vaccine development for older age groups. ObjectiveTo assess the …
contacts have stimulated vaccine development for older age groups. ObjectiveTo assess the …
Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15-through 20-month-old infants
HH Bernstein, EP Rothstein… - …, 1994 - publications.aap.org
Objective. To compare the immunogenicity and reactogenicity of a diphtheria and tetanus
toxoids and three-component acellular pertussis vaccine (DTaP) with a diphtheria and …
toxoids and three-component acellular pertussis vaccine (DTaP) with a diphtheria and …
A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15-to 20-month-old children
ME Pichichero, MA Deloria, MB Rennels… - …, 1997 - publications.aap.org
Objective. To compare the safety and immunogenicity of 12 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) with one licensed diphtheria …
vaccines combined with diphtheria and tetanus toxoids (DTaP) with one licensed diphtheria …
Rationale for use of Tdap booster vaccines for adolescent immunization: Overview of efficacy, safety, and clinical use
WP Hitchcock - Clinical pediatrics, 2006 - journals.sagepub.com
Pertussis is one of the only vaccine-preventable diseases with increasing incidence in the
United States. The incidence of pertussis infection in adolescents is a growing concern; it …
United States. The incidence of pertussis infection in adolescents is a growing concern; it …
Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents
ME Pichichero, MM Blatter, WA Kennedy, J Hedrick… - …, 2006 - publications.aap.org
BACKGROUND. The incidence of pertussis is increasing, especially in adolescents,
attributed in part to waning of immunity after childhood immunization. Recently licensed in …
attributed in part to waning of immunity after childhood immunization. Recently licensed in …
[HTML][HTML] Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines …
KR Broder, MM Cortese, JK Iskander, K Kretsinger… - MMWR Recomm …, 2006 - cdc.gov
During spring 2005, two tetanus toxoid, reduced diphtheria toxoid and acellular pertussis
vaccine (Tdap) products formulated for use in adolescents (and, for one product, use in …
vaccine (Tdap) products formulated for use in adolescents (and, for one product, use in …
Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after …
M Kovac, L Kostanyan, N Mesaros… - Human Vaccines & …, 2018 - Taylor & Francis
Pertussis is a highly contagious disease, for which periodic peaks in incidence and an
increasing number of outbreaks have been observed over the last decades. The reduced …
increasing number of outbreaks have been observed over the last decades. The reduced …
Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19–64 years of age
M Blatter, LR Friedland, WM Weston, P Li, B Howe - Vaccine, 2009 - Elsevier
PURPOSE: This study was conducted to assess the immunogenicity and safety of a tetanus
toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine containing three …
toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine containing three …
Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four-to six-year-old children
ME Pichichero, KM Edwards, EL Anderson… - …, 2000 - publications.aap.org
Objective. To evaluate the safety and immunogenicity of 6 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …